advertising
-
1.
Bouche P, Cattelin F, Saint-Jean O, et al: Clinical and electrophysiological study of the peripheral nervous system in the elderly. J Neurol 240: 263, 1993; doi: .
-
2.
Bouche P: Neuropathy of the elderly. Rev Neurol (Paris) 176: 733, 2020; doi: .
-
3.
Brisset M, Nicolas G: Peripheral neuropathies and aging. Geriatr Psychol Neuropsychiatr Vieil 16: 409, 2018; doi: .
-
4.
Hicks CW, Wang D, Windham BG, et al: Prevalence of peripheral neuropathy defined by monofilament insensitivity in middle-aged and older adults in two US cohorts. Sci Rep 11: 19159, 2021; doi: .
-
5.
Hall JE: Guyton and Hall Textbook of Medical Physiology, 13th Ed, WB Saunders, Philadelphia, 2015.
-
6.
Tentolouris A, Tentolouris N, Eleftheriadou I, et al: The performance and interrater agreement of vibration perception for the diagnosis of loss of protective sensation in people with diabetes mellitus. Int J Low Extrem Wounds 22: 72, 2023; doi: .
-
7.
Lawler FH, Mold JW, Liao X, et al: Peripheral neuropathy in older people is associated with reduced life expectancy. J Am Board Fam Med 36: 431, 2023; doi: .
-
8.
Richardson JK, Hurvitz EA: Peripheral neuropathy: a true risk factor for falls. J Gerontol A Biol Sci Med Sci 50: M211, 1995; doi: .
-
9.
Richardson JK, Ashton-Miller JA: Peripheral neuropathy: an often-overlooked cause of falls in the elderly. Postgrad Med 99: 161, 1996.
-
10.
Hafström A: Perceived and functional balance control is negatively affected by diminished touch and vibration sensitivity in relatively healthy older adults and elderly. Gerontol Geriatr Med 4: 2333721418775551, 2018; doi: .
-
11.
Riskowski JL, Quach L, Manor B, et al: Idiopathic peripheral neuropathy increases fall risk in a population-based cohort study of older adults. J Foot Ankle Res 5 (suppl 1): P19, 2012; doi: .
-
12.
Hicks CW, Wang D, Daya N, et al: The association of peripheral neuropathy detected by monofilament testing with risk of falls and fractures in older adults. J Am Geriatr Soc 71: 1902, 2023; doi: .
-
13.
Loo DS: Cutaneous fungal infections in the elderly. Dermatol Clin 22: 33, 2004; doi: .
-
14.
Levy LA: Epidemiology of onychomycosis in special-risk populations. J Am Podiatr Med Assoc 87: 546, 1997; doi: .
-
15.
Gupta AK, Venkataraman M, Talukder M: Onychomycosis in older adults: prevalence, diagnosis, and management. Drugs Aging 39: 191, 2022; doi: .
-
16.
George DH: Management of hyperkeratotic lesions in the elderly patient. Clin Podiatr Med Surg 10: 69, 1993.
-
17.
Helfand AE: Nail and hyperkeratotic problems in the elderly foot. Am Fam Physician 39: 101, 1989.
-
18.
Oyer DS, Saxon D, Shah A: Quantitative assessment of diabetic peripheral neuropathy with use of the clanging tuning fork test. Endocr Pract 13: 5, 2007; doi: .
-
19.
O’Brien T, Karem J: Combined utility of the Semmes-Weinstein monofilament and the timed vibration test in the prediction of diabetic foot ulcers. J Am Podiatr Med Assoc 112: 20, 2022; doi: .
-
20.
Centers for Medicare & Medicaid Services: Billing and coding: routine foot care and debridement of nails. Available at: https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=57759&ver=21&. Accessed December 6, 2023.
-
21.
Aronow WS, Ahn C, Gutstein H: Prevalence and incidence of cardiovascular disease in 1160 older men and 2464 older women in a long-term health care facility. J Gerontol A Biol Sci Med Sci 57: M45, 2002; doi: .
-
22.
Criqui MH, Aboyans V: Epidemiology of peripheral artery disease. Circ Res 116: 1509, 2015; doi: . Erratum in: Circ Res 117: e12, 2015.
-
23.
Criqui MH, Matsushita K, Aboyans V, et al: Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association. Circulation 144: e171, 2021; doi: . Erratum in: Circulation 144: e193, 2021.
-
24.
Elafros MA, Andersen H, Bennett DL, et al: Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments. Lancet Neurol 21: 922, 2022; doi: .
-
25.
Chang MC, Yang S: Diabetic peripheral neuropathy essentials: a narrative review. Ann Palliat Med 12: 390, 2023; doi: .
-
26.
Castelli G, Desai KM, Cantone RE: Peripheral neuropathy: evaluation and differential diagnosis. Am Fam Physician 102: 732, 2020.
Prevalence of Large Fiber Neuropathy in Nondiabetic Older Adults Seeking Routine Foot Care
Search for other papers by Todd O’Brien in
Current site
Google Scholar
PubMed
Background: Older adults qualifying for routine foot care (RFC) under the Medicare program are often diagnosed with diabetes, peripheral artery disease (PAD), or neuropathy. Specifically, large fiber neuropathy (LFN) has been shown to increase during the aging process, rendering patients more susceptible to unperceived trauma because of loss of protective sensation and an increased fall risk because of balance deficits. This study assessed the prevalence of LFN as diagnosed by the timed vibration test (TVT) in the nondiabetic segment of the Medicare population seeking RFC. A comparison was made between this group and those patients identified with PAD.
Methods: A retrospective electronic medical record review of Medicare patients seeking RFC (Current Procedural Terminology codes 11720, 11721, and 11055) was conducted in a community health center-based podiatry clinic over a 5-year period. The prevalence of LFN as diagnosed by the TVT (International Statistical Classification of Diseases, Tenth Revision code G62.9 and TVT ≤4 sec at the hallux) and PAD as diagnosed per Medicare class findings for vascular impairment (International Statistical Classification of Diseases, Tenth Revision codes I70.203 and I73.9) was identified in nondiabetic Medicare patients seeking RFC.
Results: The prevalence of LFN and PAD within the nondiabetic Medicare population seeking RFC was found to be 21.1% (91 of 431) and 27.6% (119 of 431), respectively. There was a 6.5% difference between the proportions of the LFN and PAD groups, which was significantly different (P = .026, confidence interval = 0.77–12.2%). A total of 10.9% of the population was found to have LFN and PAD concurrently. There was no significant difference between the ages of patients in the LFN and PAD groups (P = .36, standard deviation [SD] = 1.65), the LFN and LFN/PAD groups (P = .3, SD = 1.95), or the PAD and LFN/PAD groups (P = .07, SD = 1.95).
Conclusions: LFN and PAD are both present in substantial proportions in nondiabetic Medicare patients seeking RFC. The prevalence of LFN in this at-risk population highlights the importance of accurate diagnosis and implementation of preventative measures designed to mitigate unperceived foot trauma and potential falls. This is especially relevant, as neuropathy in geriatric patients has been associated with earlier mortality.
advertising
